Actively Recruiting
Incidence of 106TBL Lymph Node Metastasis
Led by Fudan University · Updated on 2025-09-10
1852
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
the study was to document the incidence of left tracheobronchial lymph node metastasis, and the risk factors of metastasis.
CONDITIONS
Official Title
Incidence of 106TBL Lymph Node Metastasis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with esophageal squamous cell carcinoma
- Clinical staging: cT1-4a N0/+ M0
- No history of other malignancy
You will not qualify if you...
- Esophageal cancer located in the neck
- Poor physical status preventing esophagectomy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China, 200032
Actively Recruiting
Research Team
B
Bin Li, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here